Sunao Kaneko

10.8k total citations
317 papers, 7.6k citations indexed

About

Sunao Kaneko is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Sunao Kaneko has authored 317 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 177 papers in Psychiatry and Mental health, 85 papers in Cellular and Molecular Neuroscience and 72 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Sunao Kaneko's work include Epilepsy research and treatment (101 papers), Pharmacological Effects and Toxicity Studies (66 papers) and Schizophrenia research and treatment (66 papers). Sunao Kaneko is often cited by papers focused on Epilepsy research and treatment (101 papers), Pharmacological Effects and Toxicity Studies (66 papers) and Schizophrenia research and treatment (66 papers). Sunao Kaneko collaborates with scholars based in Japan, China and United States. Sunao Kaneko's co-authors include Motohiro Okada, Norio Yasui‐Furukori, Shinichi Hirose, Tsuyoshi Kondo, Norio Yasui‐Furukori, Koichi Otani, Taku Nakagami, Norio Sugawara, Kazuo Mihara and Manabu Saito and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

Sunao Kaneko

311 papers receiving 7.4k citations

Peers

Countries citing papers authored by Sunao Kaneko

Since Specialization

Citations

This map shows the geographic impact of Sunao Kaneko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunao Kaneko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunao Kaneko more than expected).

Fields of papers citing papers by Sunao Kaneko

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunao Kaneko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunao Kaneko. The network helps show where Sunao Kaneko may publish in the future.

Co-authorship network of co-authors of Sunao Kaneko

This figure shows the co-authorship network connecting the top 25 collaborators of Sunao Kaneko. A scholar is included among the top collaborators of Sunao Kaneko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sunao Kaneko. Sunao Kaneko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abnormal Temporal Window of Integration in Auditory Sensory Memory in Schizophrenia 2024 ·Clinical EEG and Neuroscience ·(unknown), Hirooki Yabe, Tomiharu Hiruma, Takashi Matsuoka, (unknown), (unknown), (unknown), (unknown), Hiroshi Hoshino, Tetsuya Shiga, Itaru Miura, Koichi Hirata, Sunao Kaneko	0
2	Assessment of the long‐term efficacy and safety of adjunctive perampanel in tonic‐clonic seizures: Analysis of four open‐label extension studies 2020 ·Epilepsia ·Ivan Rektor, Gregory L. Krauss, Yushi Inoue, Sunao Kaneko, Betsy Williams, Anna Patten, Manoj Malhotra, Antonio Laurenza, Robert Wechsler	15
3	Topiramate-induced weight loss depends on level of intellectual disability in patients with epilepsy 2018 ·Epilepsy & Behavior ·Hirotaka Iwaki, Kazutaka Jin, (unknown), Nobukazu Nakasato, Sunao Kaneko	3
4	Protective Effect of Sex Hormone-Binding Globulin against Metabolic Syndrome:In VitroEvidence Showing Anti-Inflammatory and Lipolytic Effects on Adipocytes and Macrophages 2018 ·Mediators of Inflammation ·Hiroki Yamazaki, Akifumi Kushiyama, Hideyuki Sakoda, Midori Fujishiro, Takeshi Yamamotoya, Yusuke Nakatsu, Takako Kikuchi, Sunao Kaneko, Hirotoshi Tanaka, Tomoichiro Asano	63
5	Therapeutic Reference Range for Plasma Concentrations of Paroxetine in Patients With Major Depressive Disorders 2014 ·Therapeutic Drug Monitoring ·Tetsu Tomita, Norio Yasui‐Furukori, Taku Nakagami, Shoko Tsuchimine, (unknown), Ayako Kaneda, Kazuhiko Nakamura, Sunao Kaneko	18
6	Association of nonsense mutation in GABRG2 with abnormal trafficking of GABAA receptors in severe epilepsy 2014 ·Epilepsy Research ·Atsushi Ishii, (unknown), Miwa Sohda, Yoshio Misumi, Bo Zhang, Naoto Kakinuma, (unknown), Kazuyoshi Watanabe, Sén Takeda, Motohiro Okada, Shinya Ueno, Sunao Kaneko, Sachio Takashima, Shinichi Hirose	32
7	The Influence of 5-HTTLPR Genotype on the Association between the Plasma Concentration and Therapeutic Effect of Paroxetine in Patients with Major Depressive Disorder 2014 ·PLoS ONE ·Tetsu Tomita, Norio Yasui‐Furukori, Taku Nakagami, Shoko Tsuchimine, (unknown), Ayako Kaneda, Norio Sugawara, Sunao Kaneko	14
8	Visual Hallucinations During Duloxetine Treatment in a Patient With Major Depressive Disorder 2013 ·Clinical Neuropharmacology ·Tetsu Tomita, Norio Yasui‐Furukori, Sunao Kaneko	5
9	A Multicenter Open-Labeled, Follow-up Trial of Levetiracetam in Japanese Epilepsy Patients with Partial Onset Seizures 2012 ·Journal of the Japan Epilepsy Society ·Kazuichi Yagi, Shigeki Kameyama, Sunao Kaneko, Mitsukuni Murasaki, Toshio Yamauchi, Katsumi Yoshida, Atsushi Suzuki	1
10	Inverse correlation between clinical response to paroxetine and plasma drug concentration in patients with major depressive disorders 2011 ·Human Psychopharmacology Clinical and Experimental ·Norio Yasui‐Furukori, Taku Nakagami, Ayako Kaneda, Yoshimasa Inoue, Akihito Suzuki, Koichi Otani, Sunao Kaneko	17
11	Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorder 2011 ·Human Psychopharmacology Clinical and Experimental ·Norio Yasui‐Furukori, Shoko Tsuchimine, Taku Nakagami, Akira Fujii, Yasushi Sato, Tetsu Tomita, (unknown), Yoshimasa Inoue, Sunao Kaneko	15
12	Comparing the Influence of Dopamine D2 Polymorphisms and Plasma Drug Concentrations on the Clinical Response to Risperidone 2011 ·Journal of Clinical Psychopharmacology ·Norio Yasui‐Furukori, Shoko Tsuchimine, Manabu Saito, Taku Nakagami, Norio Sugawara, Akira Fujii, Sunao Kaneko	13
13	Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Levetiracetam as Add-On Therapy in Japanese Patients with Uncontrolled Partial Seizures 2010 ·Journal of the Japan Epilepsy Society ·Kazuichi Yagi, Shigeki Kameyama, Sunao Kaneko, Mitsukuni Murasaki, Toshio Yamauchi	8
14	Identification of predictors of post‐ictal delirium after electroconvulsive therapy 2009 ·Psychiatry and Clinical Neurosciences ·Atsuhiro Kikuchi, Norio Yasui‐Furukori, Akira Fujii, Hiroshi Katagai, Sunao Kaneko	34
15	Genetics of Idiopathic Epilepsies 2005 ·Epilepsia ·Shinichi Hirose, Akihisa Mitsudome, Motohiro Okada, Sunao Kaneko, (unknown)	58
16	Effects of various factors on steady‐state plasma concentrations of risperidone and 9‐hydroxyrisperidone: lack of impact of MDR‐1 genotypes 2004 ·British Journal of Clinical Pharmacology ·Norio Yasui‐Furukori, Kazuo Mihara, Takenori Takahata, Akihito Suzuki, Taku Nakagami, Ronald de Vries, Tomonori Tateishi, Tsuyoshi Kondo, Sunao Kaneko	49
17	Both 3,4-dihydroxyphenylalanine and dopamine releases are regulated by Ca2+-induced Ca2+ releasing system in rat striatum 2004 ·Neuroscience Letters ·Gang Zhu, Motohiro Okada, Shukuko Yoshida, Shinichi Hirose, Sunao Kaneko	10
18	Involuntary Movements Associated with Mianserin Treatment 1989 ·The British Journal of Psychiatry ·Koichi Otani, Sunao Kaneko, Yutaka Fukushima, (unknown)	2
19	A Rational Antiepileptic Drug Therapy of Epileptic Women in Child Bearing Age 1988 ·Psychiatry and Clinical Neurosciences ·Sunao Kaneko	2
20	EPILEPSY, PREGNANCY AND ANTIEPILEPTIC DRUGS 1986 ·Sunao Kaneko	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact